Brief: Bone Biologics Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
16/11/2023 21:52
Nov 16 (Reuters) - Bone Biologics Corp BBLG.O :
* BONE BIOLOGICS ANNOUNCES REGISTERED DIRECT OFFERING PRICED
AT-THE-MARKET UNDER NASDAQ RULES
* BONE BIOLOGICS CORP - ENTERED INTO A DEFINITIVE AGREEMENT
FOR
ISSUANCE AND SALE OF 1.1 MILLION OF ITS SHARES OF COMMON STOCK
AT $0.64 PER SHARE
Source text for Eikon: ID:nBw5bXlHwa
Further company coverage: BBLG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview